Cardinal Health, Inc. (0HTG.L)
USD 136.06
(0.57%)
USD 136.06
(0.57%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 5 Billion USD | -2.32% |
| 2023 | 5.11 Billion USD | 4.88% |
| 2022 | 4.88 Billion USD | -2.07% |
| 2021 | 4.98 Billion USD | -2.2% |
| 2020 | 5.09 Billion USD | -0.1% |
| 2019 | 5.1 Billion USD | -3.81% |
| 2018 | 5.3 Billion USD | 23.27% |
| 2017 | 4.3 Billion USD | 4.75% |
| 2016 | 4.1 Billion USD | 16.64% |
| 2015 | 3.52 Billion USD | 8.31% |
| 2014 | 3.25 Billion USD | 7.19% |
| 2013 | 3.03 Billion USD | 11.92% |
| 2012 | 2.71 Billion USD | 4.44% |
| 2011 | 2.59 Billion USD | 10.62% |
| 2010 | 2.34 Billion USD | -31.78% |
| 2009 | 3.43 Billion USD | -0.26% |
| 2008 | 3.44 Billion USD | -7.58% |
| 2007 | 3.73 Billion USD | 15.59% |
| 2006 | 3.22 Billion USD | 7.86% |
| 2005 | 2.99 Billion USD | 26.81% |
| 2004 | 2.35 Billion USD | 7.54% |
| 2003 | 2.19 Billion USD | -0.85% |
| 2002 | 2.21 Billion USD | 4.14% |
| 2001 | 2.12 Billion USD | 13.41% |
| 2000 | 1.87 Billion USD | 4.17% |
| 1999 | 1.79 Billion USD | 184.5% |
| 1998 | 632.1 Million USD | 11.9% |
| 1997 | 564.9 Million USD | 21.28% |
| 1996 | 465.8 Million USD | 44.66% |
| 1995 | 322 Million USD | 12.51% |
| 1994 | 286.2 Million USD | 281.6% |
| 1993 | 75 Million USD | 10.13% |
| 1992 | 68.1 Million USD | 29.96% |
| 1991 | 52.4 Million USD | 36.1% |
| 1990 | 38.5 Million USD | 19.94% |
| 1989 | 32.1 Million USD | 32.64% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.34 Billion USD | 6.74% |
| 2024 Q1 | 1.26 Billion USD | -5.61% |
| 2024 Q3 | 1.28 Billion USD | -4.75% |
| 2024 FY | 5 Billion USD | -2.32% |
| 2024 Q4 | 1.27 Billion USD | -0.39% |
| 2023 Q4 | 1.33 Billion USD | 6.62% |
| 2023 Q1 | 1.26 Billion USD | 2.09% |
| 2023 FY | 5.11 Billion USD | 4.88% |
| 2023 Q2 | 1.26 Billion USD | -0.47% |
| 2023 Q3 | 1.25 Billion USD | -0.71% |
| 2022 Q1 | 1.19 Billion USD | -3.4% |
| 2022 FY | 4.88 Billion USD | -2.07% |
| 2022 Q4 | 1.24 Billion USD | 2.14% |
| 2022 Q3 | 1.21 Billion USD | -1.14% |
| 2022 Q2 | 1.23 Billion USD | 3.1% |
| 2021 FY | 4.98 Billion USD | -2.2% |
| 2021 Q3 | 1.23 Billion USD | -2.53% |
| 2021 Q2 | 1.26 Billion USD | 0.64% |
| 2021 Q1 | 1.25 Billion USD | -0.87% |
| 2021 Q4 | 1.23 Billion USD | 0.32% |
| 2020 Q1 | 1.23 Billion USD | -6.21% |
| 2020 FY | 5.09 Billion USD | -0.1% |
| 2020 Q2 | 1.29 Billion USD | 4.6% |
| 2020 Q3 | 1.29 Billion USD | -0.08% |
| 2020 Q4 | 1.26 Billion USD | -2.24% |
| 2019 FY | 5.1 Billion USD | -3.81% |
| 2019 Q3 | 1.25 Billion USD | 2.46% |
| 2019 Q2 | 1.22 Billion USD | -6.86% |
| 2019 Q1 | 1.31 Billion USD | -8.64% |
| 2019 Q4 | 1.32 Billion USD | 5.6% |
| 2018 Q2 | 1.31 Billion USD | 5.62% |
| 2018 Q4 | 1.43 Billion USD | 9.79% |
| 2018 Q1 | 1.24 Billion USD | 8.64% |
| 2018 Q3 | 1.3 Billion USD | -0.61% |
| 2018 FY | 5.3 Billion USD | 23.27% |
| 2017 FY | 4.3 Billion USD | 4.75% |
| 2017 Q3 | 1.08 Billion USD | 6.15% |
| 2017 Q4 | 1.14 Billion USD | 5.33% |
| 2017 Q2 | 1.02 Billion USD | -1.63% |
| 2017 Q1 | 1.04 Billion USD | -5.44% |
| 2016 Q1 | 947 Million USD | 0.96% |
| 2016 Q2 | 1.03 Billion USD | 9.4% |
| 2016 Q3 | 1.02 Billion USD | -1.35% |
| 2016 Q4 | 1.1 Billion USD | 7.83% |
| 2016 FY | 4.1 Billion USD | 16.64% |
| 2015 Q3 | 880 Million USD | 0.57% |
| 2015 FY | 3.52 Billion USD | 8.31% |
| 2015 Q1 | 828 Million USD | -3.5% |
| 2015 Q2 | 875 Million USD | 5.68% |
| 2015 Q4 | 938 Million USD | 6.59% |
| 2014 FY | 3.25 Billion USD | 7.19% |
| 2014 Q3 | 792 Million USD | -3.65% |
| 2014 Q2 | 822 Million USD | 5.25% |
| 2014 Q4 | 858 Million USD | 8.33% |
| 2014 Q1 | 781 Million USD | -5.56% |
| 2013 FY | 3.03 Billion USD | 11.92% |
| 2013 Q4 | 827 Million USD | 8.1% |
| 2013 Q3 | 765 Million USD | 5.66% |
| 2013 Q2 | 724 Million USD | 0.84% |
| 2013 Q1 | 718 Million USD | -0.69% |
| 2012 FY | 2.71 Billion USD | 4.44% |
| 2012 Q4 | 723 Million USD | 5.9% |
| 2012 Q3 | 682.7 Million USD | 6.71% |
| 2012 Q2 | 639.8 Million USD | -0.54% |
| 2012 Q1 | 643.3 Million USD | -4.24% |
| 2011 Q3 | 701.6 Million USD | 11.72% |
| 2011 Q2 | 628 Million USD | 5.85% |
| 2011 FY | 2.59 Billion USD | 10.62% |
| 2011 Q4 | 671.8 Million USD | -4.25% |
| 2011 Q1 | 593.3 Million USD | -3.84% |
| 2010 FY | 2.34 Billion USD | -31.78% |
| 2010 Q2 | 579.8 Million USD | -0.99% |
| 2010 Q4 | 617 Million USD | -1.39% |
| 2010 Q3 | 625.7 Million USD | 7.92% |
| 2010 Q1 | 585.6 Million USD | -31.44% |
| 2009 Q4 | 854.1 Million USD | 0.46% |
| 2009 FY | 3.43 Billion USD | -0.26% |
| 2009 Q2 | 858.5 Million USD | -3.38% |
| 2009 Q3 | 850.2 Million USD | -0.97% |
| 2009 Q1 | 888.5 Million USD | -5.74% |
| 2008 Q3 | 878.4 Million USD | 10.64% |
| 2008 Q2 | 793.9 Million USD | -4.6% |
| 2008 Q4 | 942.6 Million USD | 7.31% |
| 2008 FY | 3.44 Billion USD | -7.58% |
| 2008 Q1 | 832.2 Million USD | -0.66% |
| 2007 Q1 | 819.3 Million USD | -7.09% |
| 2007 Q2 | 768.7 Million USD | -6.18% |
| 2007 Q3 | 1.38 Billion USD | 80.54% |
| 2007 FY | 3.73 Billion USD | 15.59% |
| 2007 Q4 | 837.7 Million USD | -39.64% |
| 2006 Q1 | 823.9 Million USD | 4.21% |
| 2006 FY | 3.22 Billion USD | 7.86% |
| 2006 Q4 | 881.8 Million USD | 14.0% |
| 2006 Q3 | 773.5 Million USD | -3.42% |
| 2006 Q2 | 800.9 Million USD | -2.79% |
| 2005 Q3 | 726.4 Million USD | -7.18% |
| 2005 Q2 | 782.6 Million USD | 7.94% |
| 2005 Q1 | 725 Million USD | 16.5% |
| 2005 FY | 2.99 Billion USD | 26.81% |
| 2005 Q4 | 790.6 Million USD | 8.84% |
| 2004 Q2 | 583.4 Million USD | 4.03% |
| 2004 Q1 | 560.8 Million USD | -10.86% |
| 2004 Q3 | 609.1 Million USD | 4.41% |
| 2004 FY | 2.35 Billion USD | 7.54% |
| 2004 Q4 | 622.3 Million USD | 2.17% |
| 2003 FY | 2.19 Billion USD | -0.85% |
| 2003 Q4 | 629.1 Million USD | 7.37% |
| 2003 Q1 | 539.4 Million USD | -8.85% |
| 2003 Q2 | 488.6 Million USD | -9.42% |
| 2003 Q3 | 585.9 Million USD | 19.91% |
| 2002 Q4 | 591.8 Million USD | 2.9% |
| 2002 Q3 | 575.1 Million USD | 8.35% |
| 2002 Q2 | 530.8 Million USD | 3.13% |
| 2002 Q1 | 514.7 Million USD | -6.23% |
| 2002 FY | 2.21 Billion USD | 4.14% |
| 2001 Q4 | 548.9 Million USD | -7.93% |
| 2001 Q2 | 445.4 Million USD | 4.53% |
| 2001 Q3 | 596.2 Million USD | 33.86% |
| 2001 Q1 | 426.1 Million USD | -11.16% |
| 2001 FY | 2.12 Billion USD | 13.41% |
| 2000 Q1 | 453 Million USD | -3.64% |
| 2000 Q4 | 479.6 Million USD | 21.51% |
| 2000 FY | 1.87 Billion USD | 4.17% |
| 2000 Q3 | 394.7 Million USD | -17.58% |
| 2000 Q2 | 478.9 Million USD | 5.72% |
| 1999 Q2 | 235.4 Million USD | 30.27% |
| 1999 Q3 | 511.8 Million USD | 117.42% |
| 1999 Q4 | 470.1 Million USD | -8.15% |
| 1999 FY | 1.79 Billion USD | 184.5% |
| 1999 Q1 | 180.7 Million USD | 4.94% |
| 1998 Q2 | 150.9 Million USD | 1.48% |
| 1998 Q4 | 172.2 Million USD | 8.44% |
| 1998 FY | 632.1 Million USD | 11.9% |
| 1998 Q1 | 148.7 Million USD | 2.69% |
| 1998 Q3 | 158.8 Million USD | 5.24% |
| 1997 Q4 | 144.8 Million USD | -2.16% |
| 1997 Q3 | 148 Million USD | 17.18% |
| 1997 Q1 | 120.1 Million USD | -37.48% |
| 1997 Q2 | 126.3 Million USD | 5.16% |
| 1997 FY | 564.9 Million USD | 21.28% |
| 1996 Q1 | 85.7 Million USD | 1.9% |
| 1996 Q3 | 90.9 Million USD | 1.45% |
| 1996 Q2 | 89.6 Million USD | 4.55% |
| 1996 Q4 | 192.1 Million USD | 111.33% |
| 1996 FY | 465.8 Million USD | 44.66% |
| 1995 Q4 | 84.1 Million USD | 3.06% |
| 1995 Q1 | 77.4 Million USD | -25.58% |
| 1995 Q3 | 81.6 Million USD | 3.42% |
| 1995 Q2 | 78.9 Million USD | 1.94% |
| 1995 FY | 322 Million USD | 12.51% |
| 1994 FY | 286.2 Million USD | 281.6% |
| 1994 Q1 | 21.3 Million USD | 5.97% |
| 1994 Q3 | 65.6 Million USD | 205.12% |
| 1994 Q2 | 21.5 Million USD | 0.94% |
| 1994 Q4 | 104 Million USD | 58.54% |
| 1993 Q1 | 18.6 Million USD | -2.62% |
| 1993 FY | 75 Million USD | 10.13% |
| 1993 Q4 | 20.1 Million USD | 9.24% |
| 1993 Q3 | 18.4 Million USD | -2.13% |
| 1993 Q2 | 18.8 Million USD | 1.08% |
| 1992 Q2 | 17.7 Million USD | 16.45% |
| 1992 Q3 | 20 Million USD | 12.99% |
| 1992 FY | 68.1 Million USD | 29.96% |
| 1992 Q1 | 15.2 Million USD | 0.0% |
| 1992 Q4 | 19.1 Million USD | -4.5% |
| 1991 Q2 | 13.6 Million USD | 10.57% |
| 1991 Q4 | 15.2 Million USD | -0.65% |
| 1991 Q1 | 12.3 Million USD | 12.84% |
| 1991 Q3 | 15.3 Million USD | 12.5% |
| 1991 FY | 52.4 Million USD | 36.1% |
| 1990 Q3 | 10.9 Million USD | 17.2% |
| 1990 FY | 38.5 Million USD | 19.94% |
| 1990 Q1 | 10.9 Million USD | 0.0% |
| 1990 Q4 | 10.9 Million USD | 0.0% |
| 1990 Q2 | 9.3 Million USD | -14.68% |
| 1989 FY | 32.1 Million USD | 32.64% |
| 1989 Q3 | -682.2 Million USD | 0.0% |
| 1989 Q2 | - USD | 100.0% |
| 1989 Q1 | -682.2 Million USD | 0.0% |
| 1989 Q4 | - USD | 100.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Phreesia, Inc. | 369.84 Million USD | -1251.932% |
| Accuray Incorporated | 142.61 Million USD | -3405.893% |
| Align Technology, Inc. | 2.07 Billion USD | -140.752% |
| Elevance Health Inc. | 36.23 Billion USD | 86.202% |
| AxoGen, Inc. | 149.33 Million USD | -3248.154% |
| Boston Scientific Corporation | 7.5 Billion USD | 33.387% |
| CVS Health Corporation | 40.68 Billion USD | 87.711% |
| Centene Corporation | 138.33 Billion USD | 96.386% |
| DaVita Inc. | 1.47 Billion USD | -239.217% |
| HCA Healthcare, Inc. | 45.43 Billion USD | 88.996% |
| Hologic, Inc. | 1.26 Billion USD | -294.446% |
| Humana Inc. | 102.36 Billion USD | 95.115% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -357.523% |
| Laboratory Corporation of America Holdings | 2.02 Billion USD | -147.353% |
| Masimo Corporation | 867 Million USD | -476.701% |
| McKesson Corporation | 8.67 Billion USD | 42.363% |
| Patterson Companies, Inc. | 1.12 Billion USD | -343.531% |
| Quest Diagnostics Incorporated | 1.61 Billion USD | -210.559% |
| ResMed Inc. | 1.36 Billion USD | -265.397% |
| Henry Schein, Inc. | 2.93 Billion USD | -70.242% |
| Teladoc Health, Inc. | 2.09 Billion USD | -139.127% |
| Universal Health Services, Inc. | 9.2 Billion USD | 45.701% |
| Veeva Systems Inc. | 1.25 Billion USD | -297.757% |
| Baxter International Inc. | 5.27 Billion USD | 5.159% |
| Becton, Dickinson and Company | 6.71 Billion USD | 25.507% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | -68.765% |
| Danaher Corporation | 8.75 Billion USD | 42.89% |
| Stryker Corporation | 9.2 Billion USD | 45.705% |
| Medtronic plc | 16.12 Billion USD | 69.0% |